Lexington Biosciences, Inc. is a medical device company, which engages in the research and development of non-diagnostic devices. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2017-06-01. The device measures the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke. The firm is in the final stages of releasing the developed product for clinical studies. The firm's goal is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health.
Follow-Up Questions
Quelle est la performance du prix de l'action LXGTF ?
Le prix actuel de LXGTF est de $0.0001, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Lexington Biosciences Holdings Corp ?
Lexington Biosciences Holdings Corp appartient à l'industrie N/A et le secteur est N/A
Quelle est la capitalisation boursière de Lexington Biosciences Holdings Corp ?
La capitalisation boursière actuelle de Lexington Biosciences Holdings Corp est de $378.684
